Brigham and Women's Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Brigham and Women's Hospital sits in the top decile of US sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count).
Brigham and Women's Hospital: 937 sponsored US clinical trials, 145 recruiting.
Brigham and Women's Hospital sponsors 937 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 608 completed. 124 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
Brigham and Women's Hospital ranks in the top decile of sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
608 of 677 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
937 total, page 2 of 19
Safety and Feasibility of Tele-supervised Home-based Transcranial Direct Current Stimulation in Parkinson's Disease
NCT06804668
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
NCT06376734
Embolization Treatment of Chronic Refractory Shoulder Tendinopathy
NCT06095050
Leveraging Social Networks to Improve Sleep and Mindfulness Among Older Adults in Residential Housing Facilities
NCT06989619
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
NCT06328127
Can Food Timing Reduce Your Diabetes Risk?
NCT05862818
Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans
NCT06105164
Eating to Adjust the Timing System
NCT05800990
Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis
NCT06569147
Effect of Physical Activity Pattern on Cardiometabolic Health
NCT05838508
Care Transitions App for Patients With Multiple Chronic Conditions
NCT06051058
LIFT: Life Improvement Trial
NCT06366724
The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
NCT07315997
AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention
NCT06235112
Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
NCT06252129
Exercise Training in Transthyretin Cardiac Amyloidosis
NCT05797857
Understanding the Acute Pain Phenotype in Patients Undergoing Surgery
NCT06466941
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
NCT06483139
Experiment 2: One Target in Many Situations
NCT06934148
Mixed Vs Blocked Search: Four Unique Tasks
NCT06933693
Experiment 3: Mixed vs Blocked; Dashboard Paradigm
NCT06934213
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
NCT06190158
Study on Allopregnanolone and Depression in Women Across the Menopause Transition
NCT06238700
Ergonomics in the Cardiac Catheterization Laboratory
NCT06506968
Preventing Injured Knees From osteoArthritis: Severity Outcomes
NCT06096259
A Hybrid Effectiveness Implementation Trial Evaluating Behavioral Treatments for Insomnia for Socioeconomically Disadvantaged Adults in Primary Care
NCT05759065
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
NCT06099093
Digital Health Navigation for Latino Patients With Type II Diabetes
NCT06283992
Reversible Effect of Falling Ventilatory Drive in Drive-dependent OSA
NCT06091098
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
NCT06588452
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
NCT06062745
Acetazolamide as a Means to Mitigate Falling Ventilatory Drive and Drive-dependent OSA
NCT06091085
Trazodone on OSA Endotypes
NCT06286189
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
NCT06538376
Detoxification of the Liver In PSC (Dolphin)
NCT05835505
ED90 of Bupivacaine After Lidocaine Test Dose with DPE and EPL
NCT06146842
Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD
NCT05817825
Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
NCT05553782
Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment
NCT06069622
Down Syndrome Obstructive Sleep Apnea
NCT06043440
Impact of Intensive Computerized Cognitive Training
NCT06130735
MCT for the Harvard/UCSF ROBIN Center
NCT06000787
Cerebellar TMS and Satiety in Prader-Willi Syndrome
NCT05938543
Ultrasound Therapy In Cardiac Amyloidosis
NCT04667494
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
NCT05593055
Trial of Variable Dialysate Bicarbonate
NCT05814146
MRI Guided Prostate Biopsy
NCT06302595
Rescue Pharmacotherapy for OSA
NCT05293600
Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions - Part II
NCT05555875
NAD Augmentation in Diabetes Kidney Disease
NCT05759468
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 90 |
| Phase 2 | 107 |
| Phase 3 | 47 |
| Phase 4 | 77 |
Therapeutic Areas
What is open in the Brigham and Women's Hospital pipeline
145 recruiting of 937 indexed (15% open); 608 completed (65%).
Phase mix: 124 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Brigham and Women's Hospital: open-pipeline peers nationwide
Peers matched on 937 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 937 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of Minnesota · 966 trials · 19% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Incyte Corporation · 15% recruiting · 239 trials
- Northwestern University · 15% recruiting · 1,209 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Brigham and Women's Hospital page
937 registered trials is a research-attention snapshot, not an endorsement of Brigham and Women's Hospital or any single study.
- 145 of Brigham and Women's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition Brigham and Women's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Brigham and Women's Hospital pipeline card: 937 registered trials from official public datasets.Report a data error.